Protocol Number: 92-C-0094

Title:

Continuing Care and Treatment for Patients in the Center for Cancer Research

Number:

92-C-0094

Summary:

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Sponsoring Institute:

National Cancer Institute (NCI)

Recruitment Detail

Type: Active Accrual Of New Subjects

Gender: Male & Female

Referral Letter Required: No

Population Exclusion(s): None

Eligibility Criteria:

INCLUSION CRITERIA:

Eligible patients include those who have been previously enrolled on an approved NCI research protocol.

A CCR investigator decides that it is in the best interests of the patient and the NCI for the patient to be enrolled on this protocol and continue to receive care and follow-up at the NIH.

The patient or guardian signs the consent.

Special Instructions: Currently Not Provided

Keywords:

Standard Care

Follow-Up

Bridge Protocol

Recruitment Keywords:

None

Conditions:

Acquired Immunodeficiency Syndrome

Neoplasm

Skin Disease

HIV Infections

Investigational Drug(s):

None

Investigational Device(s):

None

Contacts:

CSSC
Clinical Studies Support Center/NCI
164 Rollins Avenue
2nd FLoor
Rockville, MD 20852
Phone: (888) 624-1937
Fax: (301) 881-8239

Electronic Address: ncicssc@mail.nih.gov

Citations: Not Provided

• Questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
• Technical questions regarding the Clinical Center web site, please contact the Department of Networks and Applications, CC.

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Warren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/23/2004